XML 16 R6.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (9,060,658) $ (6,209,768)
Adjustments to Reconcile Net Loss to Net Cash Used In Operating Activities:    
Depreciation and amortization expense 43,930 25,903
Amortization of debt discounts 5,681,613 518,481
Gain on sale of subsidiary (146,647)
Loss on extinguishment of debt 1,464,698
Gain on forgiveness of debt (47,717)
Loss on debt modification 1,942,156
Stock-based compensation 242,002 338,792
Issuance of common stock for services 401,800
Fair value of warrants issued for services 157,969 368,003
Gain on exchange of equity investments, and gain on change in fair value (2,500,000)
Loss on goodwill impairment 1,949,884
Changes in Assets and Liabilities:    
Accounts receivable 483,820 (534,909)
Accounts receivable - related party (18,368) (171,392)
Inventory 1,431,012 (2,623,788)
Prepaid expenses 864,925 (669,713)
Prepaid expenses - related party (2,232,089) (2,709,449)
Other assets 846,322 (531,324)
Accounts payable and accrued expenses (332,749) 496,450
Accounts payable and accrued expenses - related party (296,974) 312,666
Customer advances (125,400)
Other current liabilities 31,116
Taxes payable 64,885 278,223
Other liabilities (49,152)
NET CASH USED IN OPERATING ACTIVITIES (1,555,305) (8,760,141)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of fixed assets (503,362) (55,337)
Cash received from acquisition 307,590 40,858
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES (195,772) (14,479)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Payment of convertible note payable (3,557,381) (239,286)
Proceeds from convertible note payable 1,845,000 2,686,000
Payment of related party note payable (18,330) (84,755)
Proceeds from related party note payable 1,718,400
Payment of note payable (1,259,804) (487,476)
Proceeds from note payable 403,957 7,541,413
Payment of related party loan (631,166) (978,730)
Proceeds from related party loan 2,408,965 817,040
Payment of loans payable (20,437)
Payment of lines of credit (437,576)
Proceeds from lines of credit 41,700
Proceeds from issuance of share settled debt obligation 1,554,590
Sale of common stock and warrants 91,780
Purchase of treasury stock (80,053) (34,460)
NET CASH PROVIDED BY FINANCING ACTIVITIES 1,988,302 9,291,089
Effect of exchange rate changes on cash (155,735) (450,206)
NET INCREASE IN CASH 81,490 66,263
CASH AT BEGINNING OF YEAR 782,853 716,590
CASH AT END OF YEAR 864,343 782,853
Supplemental Disclosure of Cash Flow Information    
Cash paid during the period: Interest 299,946 130,531
Cash paid during the period: Income Tax
Supplemental Disclosure of Non-Cash Investing and Financing Activities    
Issuance of common stock related to the acquisition of Decahedron 1,479,000
Issuance of note payable related to the acquisition of Cosmofarm 227,912
Reversal of proceeds due from noteholder due to repayment of note 24,044
Proceeds due from sale of subsidiary 5,811
Pre-delivery shares issued for future conversion of convertible notes payable 1,054
Related party accrual for repurchase of shares of common stock 48,683 61,422
Discounts related to warrants issued with convertible debentures 910,078 1,545,288
Discounts related to beneficial conversion features of convertible debentures 934,922 1,140,711
Conversion of convertible notes and accrued interest to common stock, Amount $ 1,719,395